|
1
|
Kumar R, Chaudhary K, Gupta S, Singh H,
Kumar S, Gautam A, Kapoor P and Raghava GP: CancerDR: Cancer drug
resistance database. Sci Rep. 3:14452013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Strohecker AM and White E: Targeting
mitochondrial metabolism by inhibiting autophagy in BRAF-driven
cancers. Cancer Discov. 4:766–772. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Humphrey RW, Brockway-Lunardi LM, Bonk DT,
Dohoney KM, Doroshow JH, Meech SJ, Ratain MJ, Topalian SL and
Pardoll DM: Opportunities and challenges in the development of
experimental drug combinations for cancer. J Natl Cancer Inst.
103:1222–1226. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Richards MA: The size of the prize for
earlier diagnosis of cancer in England. Brit J Cancer. 101 Suppl
2:S125–S129. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dickinson BC, Srikun D and Chang CJ:
Mitochondrial-targeted fluorescent probes for reactive oxygen
species. Curr Opin Chem Biol. 14:50–56. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu Z and Xu L: Fluorescent probes for the
selective detection of chemical species inside mitochondria. Chem
Commun (Camb). 52:1094–1119. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang C, Liu T, Su Y, Luo S, Zhu Y, Tan X,
Fan S, Zhang L, Zhou Y, Cheng T and Shi C: A near-infrared
fluorescent heptamethine indocyanine dye with preferential tumor
accumulation for in vivo imaging. Biomaterials. 31:6612–6617. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang X, Shi C, Tong R, Qian W, Zhau HE,
Wang R, Zhu G, Cheng J, Yang VW, Cheng T, et al: Near IR
heptamethine cyanine dye-mediated cancer imaging. Clin Cancer Res.
16:2833–2844. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo S, Zhang E, Su Y, Cheng T and Shi C: A
review of NIR dyes in cancer targeting and imaging. Biomaterials.
32:7127–7138. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tan X, Luo S, Wang D, Su Y, Cheng T and
Shi C: A NIR heptamethine dye with intrinsic cancer targeting,
imaging and photosensitizing properties. Biomaterials.
33:2230–2239. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim K, Kim JH, Park H, Kim YS, Park K, Nam
H, Lee S, Park JH, Park RW, Kim IS, et al: Tumor-homing
multifunctional nanoparticles for cancer theragnosis: Simultaneous
diagnosis, drug delivery, and therapeutic monitoring. J Control
Release. 146:219–227. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Majumdar D, Peng XH and Shin DM: The
medicinal chemistry of theragnostics, multimodality imaging and
applications of nanotechnology in cancer. Curr Top Med Chem.
10:1211–1226. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang X, Sun J, Zhang W, Ma X, Lv J and
Tang B: A near-infrared ratiometric fluorescent probe for rapid and
highly sensitive imaging of endogenous hydrogen sulfide in living
cells. Chem Sci. 4:2551–2556. 2013. View Article : Google Scholar
|
|
15
|
Xu W, Teoh CL, Peng J, Su D, Yuan L and
Chang YT: A mitochondria-targeted ratiometric fluorescent probe to
monitor endogenously generated sulfur dioxide derivatives in living
cells. Biomaterials. 56:1–9. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pathania D, Millard M and Neamati N:
Opportunities in discovery and delivery of anticancer drugs
targeting mitochondria and cancer cell metabolism. Adv Drug Deliv
Rev. 61:1250–1275. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ross MF, Kelso GF, Blaikie FH, James AM,
Cochemé HM, Filipovska A, Da Ros T, Hurd TR, Smith RA and Murphy
MP: Lipophilic triphenylphosphonium cations as tools in
mitochondrial bioenergetics and free radical biology. Biochemistry
(Mosc). 70:222–230. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tan X, Luo S, Wang D, Su Y, Cheng T and
Shi C: A NIR heptamethine dye with intrinsic cancer targeting,
imaging and photosensitizing properties. Biomaterials.
33:2230–2239. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Saw PE, Park J, Jon S and Farokhzad OC: A
drug-delivery strategy for overcoming drug resistance in breast
cancer through targeting of oncofetal fibronectin. Nanomedicine.
13:713–722. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhitomirsky B and Assaraf YG: Lysosomes as
mediators of drug resistance in cancer. Drug Resist Updat.
24:23–33. 2016. View Article : Google Scholar : PubMed/NCBI
|
